Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

95 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
A TLR9 agonist enhances therapeutic effects of telomerase genetic vaccine.
Conforti A, Cipriani B, Peruzzi D, Dharmapuri S, Kandimalla ER, Agrawal S, Mori F, Ciliberto G, La Monica N, Aurisicchio L. Conforti A, et al. Among authors: la monica n. Vaccine. 2010 Apr 30;28(20):3522-30. doi: 10.1016/j.vaccine.2010.03.020. Epub 2010 Mar 21. Vaccine. 2010. PMID: 20332048
Treatment of mammary carcinomas in HER-2 transgenic mice through combination of genetic vaccine and an agonist of Toll-like receptor 9.
Aurisicchio L, Peruzzi D, Conforti A, Dharmapuri S, Biondo A, Giampaoli S, Fridman A, Bagchi A, Winkelmann CT, Gibson R, Kandimalla ER, Agrawal S, Ciliberto G, La Monica N. Aurisicchio L, et al. Among authors: la monica n. Clin Cancer Res. 2009 Mar 1;15(5):1575-84. doi: 10.1158/1078-0432.CCR-08-2628. Epub 2009 Feb 24. Clin Cancer Res. 2009. PMID: 19240169
MMP11: a novel target antigen for cancer immunotherapy.
Peruzzi D, Mori F, Conforti A, Lazzaro D, De Rinaldis E, Ciliberto G, La Monica N, Aurisicchio L. Peruzzi D, et al. Among authors: la monica n. Clin Cancer Res. 2009 Jun 15;15(12):4104-13. doi: 10.1158/1078-0432.CCR-08-3226. Epub 2009 Jun 9. Clin Cancer Res. 2009. PMID: 19509157
Phase 1 studies of the safety and immunogenicity of electroporated HER2/CEA DNA vaccine followed by adenoviral boost immunization in patients with solid tumors.
Diaz CM, Chiappori A, Aurisicchio L, Bagchi A, Clark J, Dubey S, Fridman A, Fabregas JC, Marshall J, Scarselli E, La Monica N, Ciliberto G, Montero AJ. Diaz CM, et al. Among authors: la monica n. J Transl Med. 2013 Mar 8;11:62. doi: 10.1186/1479-5876-11-62. J Transl Med. 2013. PMID: 23497415 Free PMC article. Clinical Trial.
95 results